Top movers analysis one hour before the close of the markets on 2026-07-22: top gainers and losers in today's session.
Rani Therapeutics Holdings Inc RANI
$0.77
▼ -5.63%
($-0.05)
⬇️ Below Yest. Low
📅 Earnings This Week
Open
$0.82
Prev Close
$0.82
Day Range
$0.76 – $0.84
52W Range
$0.44 – $3.87
Market Cap
$105.56M
Beta
0.76
EPS (TTM)
$-0.41
📋 Company Profile
| Industry | Pharmaceuticals |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2021-07-30 |
| Shares Out. | 136,260,000 |
| Website | ranitherapeutics.com/ ↗ |
| Phone | 14084573700 |
| Employees | 69 |
| Revenue | $1.7M |
| Gross Profit | $1.7M |
| Net Income | -$8.0M |
| Free Cash Flow | -$17.1M |
| Total Assets | $51.9M |
| Total Liabilities | $16.3M |
| Equity | $35.5M |
About Rani Therapeutics Holdings Inc
Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. The company has developed the RaniPill capsule, which is designed to deliver a wide variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. RaniPill is a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The company is also engaged in developing RaniPill HC, which is intended to enable the delivery of drug payloads in liquid form with high bioavailability.
Rani Therapeutics Holdings Inc is a publicly traded company under the ticker symbol RANI on the NASDAQ NMS - GLOBAL MARKET, operating in the Pharmaceuticals industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
10 analysts (2026-07-01)